{"id":32562,"date":"2026-02-09T06:56:41","date_gmt":"2026-02-09T06:56:41","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/cancer-immunotherapy-market-mordor\/"},"modified":"2026-09-04T09:55:29","modified_gmt":"2026-09-04T00:55:29","slug":"cancer-immunotherapy-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/cancer-immunotherapy-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc554 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026\ub144 ~ 2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cancer-immunotherapy-market-1750419503910-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cancer-immunotherapy-market-size-image-1767807525060.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uace0\ud615\uc554\uc758 \uc804 \uc138\uacc4\uc801 \ubc1c\uc0dd\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \ud654\ud559\uc694\ubc95 \ubc0f \ud45c\uc801 \uc18c\ubd84\uc790 \uc81c\uc81c \ub300\ube44 \uc6b0\uc218\ud55c \uc7a5\uae30 \uc0dd\uc874\uc728<\/li>\n<li class=\"toc-level-3\">4.2.3 PD-1\/PD-L1 \uc5b5\uc81c\uc81c\uc5d0 \ub300\ud55c FDA\/EMA \ub77c\ubca8 \uc2b9\uc778 \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.4 \ud6c4\uae30 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0 \uc9c4\uc785\ud558\ub294 CAR-T \ubc0f \uc774\uc911 \ud2b9\uc774\uc131 \ud56d\uccb4\uc758 \ube60\ub978 \ud30c\uc774\ud504\ub77c\uc778<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \ucd5c\uc801\ud654\ub41c \uc2e0\uc0dd\ud56d\uc6d0 \uc608\uce21\uc73c\ub85c \ub9de\ucda4\ud615 \ubc31\uc2e0 \ub9ac\ub4dc \ud0c0\uc784 \ub2e8\ucd95<\/li>\n<li class=\"toc-level-3\">4.2.6 \ud604\uc7a5 \ubc14\uc774\uc624\ub9ac\uc561\ud130\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub418\ub294 \ubcd1\uc6d0 \ub0b4 TIL \uc81c\uc870 \ucc44\ud0dd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uce58\ub8cc\uc81c \uc815\uac00 30\ub9cc \ub2ec\ub7ec \ucd08\uacfc \ubc0f \uc0c1\ud658 \ud55c\ub3c4<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc9d1\uc911 \uad00\ub9ac\uac00 \ud544\uc694\ud55c \uba74\uc5ed \uad00\ub828 \ubd80\uc791\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.3 \uae00\ub85c\ubc8c \uac00\uaca9 \ud1b5\ub85c\ub97c \uc555\ubc15\ud558\ub294 \uc2e0\ud765 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec PD-1<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc790\uac00 \uc138\ud3ec \uce58\ub8cc\uc81c\ub97c \uc704\ud55c \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uacf5\uae09 \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778\n<ul>\n<li class=\"toc-level-3\">4.4.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc554 \ubc31\uc2e0<\/li>\n<li class=\"toc-level-3\">5.1.3 \uba74\uc5ed\uc870\uc808\uc81c (\uc0ac\uc774\ud1a0\uce74\uc778, \ubcf4\uc870\uc81c)<\/li>\n<li class=\"toc-level-3\">5.1.4 \uc138\ud3ec \uae30\ubc18 \uce58\ub8cc\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.5 \uc885\uc591 \uc6a9\ud574 \ubc14\uc774\ub7ec\uc2a4 \uce58\ub8cc\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.6 \ubcd1\uc6a9 \uc694\ubc95<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc554 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud3d0\uc554<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc720\ubc29\uc554<\/li>\n<li class=\"toc-level-3\">5.2.3 \ud751\uc0c9\uc885 &amp; \ud53c\ubd80\uc554<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc804\ub9bd\uc120\uc554<\/li>\n<li class=\"toc-level-3\">5.2.5 \ud608\uc561\uc554 (\ubc31\ud608\ubcd1, \ub9bc\ud504\uc885, \uace8\uc218\uc885)<\/li>\n<li class=\"toc-level-3\">5.2.6 \uae30\ud0c0 (\ub300\uc7a5\uc554, \uc704\uc554, \uc2e0\uc7a5\uc554 \ub4f1)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubcd1\uc6d0 &amp; \ud074\ub9ac\ub2c9<\/li>\n<li class=\"toc-level-3\">5.3.2 \ud559\uc220 &amp; \uc554 \uc5f0\uad6c \uc13c\ud130<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc678\ub798 &amp; \uc804\ubb38 \uc8fc\uc785 \uc13c\ud130<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc815\ub9e5 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.4.2 \ud53c\ud558 \/ \uc885\uc591 \ub0b4<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uc720\ub7fd \uae30\ud0c0<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uae30\ud0c0<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \ub0a8\ubbf8 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uc2e0 \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 \uc554\uc820 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.2 \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74 PLC<\/li>\n<li class=\"toc-level-3\">6.3.3 \ube0c\ub9ac\uc2a4\ud1a8-\ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045 Co.<\/li>\n<li class=\"toc-level-3\">6.3.4 \uba38\ud06c &amp; Co., Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 F. \ud638\ud504\ub9cc-\ub77c \ub85c\uc288 Ltd<\/li>\n<li class=\"toc-level-3\">6.3.6 \ud654\uc774\uc790 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.7 \ub178\ubc14\ud2f0\uc2a4 AG<\/li>\n<li class=\"toc-level-3\">6.3.8 GSK plc<\/li>\n<li class=\"toc-level-3\">6.3.9 \uc77c\ub77c\uc774 \ub9b4\ub9ac \uc564 \ucef4\ud37c\ub2c8<\/li>\n<li class=\"toc-level-3\">6.3.10 \uc560\ube0c\ube44 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.11 \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8 (\uc580\uc13c)<\/li>\n<li class=\"toc-level-3\">6.3.12 \ub9ac\uc81c\ub124\ub860 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4<\/li>\n<li class=\"toc-level-3\">6.3.13 \uc0ac\ub178\ud53c<\/li>\n<li class=\"toc-level-3\">6.3.14 \ubca0\uc774\uc9c4 Ltd<\/li>\n<li class=\"toc-level-3\">6.3.15 \uc2dc\uc820 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.16 \ubc14\uc774\uc624\uc5d4\ud14d SE<\/li>\n<li class=\"toc-level-3\">6.3.17 \ubaa8\ub354\ub098, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.18 \uc544\uc774\uc624\ubc18\uc2a4 \ubc14\uc774\uc624\ud14c\ub77c\ud4e8\ud2f1\uc2a4<\/li>\n<li class=\"toc-level-3\">6.3.19 OSE \uc774\ubba4\ub178\ud14c\ub77c\ud4e8\ud2f1\uc2a4 SA<\/li>\n<li class=\"toc-level-3\">6.3.20 \uc774\ub178\ubca4\ud2b8 \ubc14\uc774\uc624\ub85c\uc9c1\uc2a4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc554 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5 \uac1c\uc694 (2026-2031\ub144)<\/p>\n<p># 1. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc804\ub9dd<\/p>\n<p>\uc554 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc740 2025\ub144 1,448\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc600\uc73c\uba70, 2026\ub144 1,645.1\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 3,114.3\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud558\uc5ec \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 13.62%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c \ubd80\uc0c1\ud560 \uac83\uc774\uba70, \ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p># 2. \uc2dc\uc7a5 \ubd84\uc11d \ubc0f \uc8fc\uc694 \ub3d9\ud5a5<\/p>\n<p>\uc554 \uba74\uc5ed\uce58\ub8cc\ub294 \uc2e4\ud5d8 \ub2e8\uacc4\ub97c \ub118\uc5b4 \ud45c\uc900 \uc885\uc591 \uce58\ub8cc\uc758 \ud575\uc2ec\uc73c\ub85c \uc790\ub9ac\ub9e4\uae40\ud558\uace0 \uc788\uc73c\uba70, 2024\ub144 2\uc6d4 FDA\uc758 \uc9c4\ud589\uc131 \ud751\uc0c9\uc885 \uce58\ub8cc\uc81c &#8216;\ub9ac\ud544\ub8e8\uc140(lifileucel)&#8217; \uc2b9\uc778\uacfc \uac19\uc740 \uc8fc\uc694 \uc2b9\uc778\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub300\uaddc\ubaa8 \uc81c\uc870 \ud22c\uc790, \uc131\uacfc \uae30\ubc18 \uacc4\uc57d\uc5d0 \ub300\ud55c \uc9c0\ubd88\uc790\uc758 \uc218\uc6a9 \ud655\ub300, \ubcd1\uc6a9 \uc694\ubc95 \uc784\uc0c1 \uacb0\uacfc\uc758 \uae0d\uc815\uc801 \ubc1c\ud45c\uac00 \uc131\uc7a5 \ubaa8\uba58\ud140\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ubc0f mRNA \ud569\uc131 \uacf5\uae09\ub9dd\uc758 \uc131\uc219\uc740 \uc0dd\uc0b0 \uc704\ud5d8\uc744 \ub0ae\ucd94\uace0 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc\ub97c \ud655\ub300\ud558\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc758 \uaddc\uc81c \uc870\ud654 \ubc0f \uc5ed\ub7c9 \uac15\ud654\ub294 \ubd81\ubbf8\uc758 \uc9c0\ubc30\ub825\uacfc \uade0\ud615\uc744 \uc774\ub8e8\uba70 \uc0c8\ub85c\uc6b4 \uc131\uc7a5 \ub3d9\ub825\uc744 \uc81c\uacf5\ud558\uace0 \uc788\uc73c\uba70, \ud604\uae08 \ubcf4\uc720\ub7c9\uc774 \ub9ce\uc740 \uae30\uc874 \uae30\uc5c5\ub4e4\uc774 \ucc28\uc138\ub300 \uce58\ub8cc\ubc95 \ud655\ubcf4\ub97c \uc704\ud574 \uc804\ubb38 \ud601\uc2e0 \uae30\uc5c5\uc744 \uc778\uc218\ud558\uba70 \uacbd\uc7c1\uc774 \uc2ec\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 3. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<\/p>\n<p>3.1. \uc131\uc7a5 \ub3d9\ub825 (Drivers)<\/p>\n<p>*   \uace0\ud615\uc554\uc758 \uc804 \uc138\uacc4\uc801 \ubc1c\ubcd1\ub960 \uc99d\uac00: \uc0dd\ud65c \uc2b5\uad00 \uad00\ub828 \uc704\ud5d8 \uc694\uc778 \ubc0f \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00\ub85c \ud3d0\uc554, \ub300\uc7a5\uc554, \uc720\ubc29\uc554 \ub4f1 \uce58\ub8cc \uac00\ub2a5\ud55c \ud658\uc790\uad70\uc774 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc885\uc591\ud559\ud68c\ub294 \ubc14\uc774\uc624\ub9c8\ucee4 \uac80\uc0ac\ub97c \uad8c\uace0\ud558\uba70 \uba74\uc5ed\uce58\ub8cc \uc694\ubc95\uc73c\ub85c\uc758 \uc870\uae30 \ubd84\ub958\ub97c \ucd09\uc9c4\ud558\uace0 \uc788\uc73c\uba70, \uacf5\uacf5 \ubd80\ubb38\uc758 \uc554 \uc778\uc2dd \ucea0\ud398\uc778\uacfc \uc815\ubc00 \uc758\uc57d\ud488\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300\uac00 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud654\ud559\uc694\ubc95 \ubc0f \ud45c\uc801 \uc18c\ubd84\uc790 \uc81c\uc81c \ub300\ube44 \uc6b0\uc218\ud55c \uc7a5\uae30 \uc0dd\uc874\uc728: CheckMate 9LA \uc5f0\uad6c\uc5d0\uc11c \ub2c8\ubcfc\ub8e8\ub9d9+\uc774\ud544\ub9ac\ubb34\ub9d9+\ud654\ud559\uc694\ubc95\uc774 \uc804\uc774\uc131 \ube44\uc18c\uc138\ud3ec\ud3d0\uc554\uc5d0\uc11c \ud654\ud559\uc694\ubc95 \ub2e8\ub3c5 \ub300\ube44 \uc6b0\uc218\ud55c \uc804\uccb4 \uc0dd\uc874\uc728(18% vs 11%)\uc744 \ubcf4\uc774\uba70 \uba74\uc5ed\uce58\ub8cc\uc758 \uc9c0\uc18d\uc801\uc778 \uc774\uc810\uc744 \ud655\uc778\ud588\uc2b5\ub2c8\ub2e4. PD-L1 \uace0\ubc1c\ud604 \uc885\uc591\uc5d0 \ub300\ud55c 1\ucc28 \uce58\ub8cc\uc81c\ub85c \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c\uac00 \uc6b0\uc120\uc21c\uc704\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   PD-1\/PD-L1 \uc5b5\uc81c\uc81c\uc5d0 \ub300\ud55c FDA\/EMA \uc2b9\uc778 \ud655\ub300: 2025\ub144 \ub2c8\ubcfc\ub8e8\ub9d9-\uc774\ud544\ub9ac\ubb34\ub9d9\uc758 dMMR\/MSI-H \uc804\uc774\uc131 \ub300\uc7a5\uc554\uc5d0 \ub300\ud55c \uc0c8\ub85c\uc6b4 \uc801\uc751\uc99d \uc2b9\uc778 \ub4f1 \ub2e4\uc218\uc758 \uc2b9\uc778\uc774 \uc774\ub8e8\uc5b4\uc84c\uc2b5\ub2c8\ub2e4. \ud53c\ud558\uc8fc\uc0ac\ud615 \ub2c8\ubcfc\ub8e8\ub9d9 \uc81c\ud615 \uc2b9\uc778\uc740 \uce58\ub8cc \uc2dc\uac04 \ubc0f \ube44\uc6a9\uc744 \uc808\uac10\ud558\uc5ec \uc9c0\uc5ed \ubcd1\uc6d0\uc758 \ucc44\ud0dd\ub960\uc744 \ub192\uc774\uace0 \uc788\uc73c\uba70, FDA\uc640 EMA \uac04\uc758 \uc870\ud654\ub41c \uac80\ud1a0 \uc77c\uc815\uc73c\ub85c \uae00\ub85c\ubc8c \ucd9c\uc2dc\uac00 \uac00\uc18d\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   CAR-T \ubc0f \uc774\uc911\ud2b9\uc774\ud56d\uccb4 \ud30c\uc774\ud504\ub77c\uc778\uc758 \ube60\ub978 \ubc1c\uc804: 400\uac1c \uc774\uc0c1\uc758 CAR-T \ud6c4\ubcf4 \ubb3c\uc9c8\uacfc \uc774\uc911\ud2b9\uc774\ud56d\uccb4\ub4e4\uc774 \uc8fc\uc694 \uc784\uc0c1 \uacb0\uacfc \ubc1c\ud45c\ub97c \uc55e\ub450\uace0 \uc788\uc2b5\ub2c8\ub2e4. BioNTech\uc758 BNT327(PD-L1\/VEGF-A \uc774\uc911\ud2b9\uc774\ud56d\uccb4)\uc740 \uad11\ubc94\uc704 \uc18c\uc138\ud3ec\ud3d0\uc554\uc5d0\uc11c 85.4%\uc758 \uc804\uccb4 \ubc18\uc751\ub960\uc744 \ubcf4\uc774\uba70 \ub2e4\uc911 \ud45c\uc801 \uacb0\ud569\uc758 \ud6a8\ub2a5\uc744 \uc785\uc99d\ud588\uc2b5\ub2c8\ub2e4. \ud604\uc7a5 \ubc14\uc774\uc624\ub9ac\uc561\ud130 \ub4f1 \uc81c\uc870 \ubc1c\uc804\uc73c\ub85c \uc790\uac00 CAR-T \uce58\ub8cc\uc81c \ub9ac\ub4dc \ud0c0\uc784\uc774 \ub2e8\ucd95\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   AI \ucd5c\uc801\ud654\ub41c \uc2e0\uc0dd\ud56d\uc6d0 \uc608\uce21\uc744 \ud1b5\ud55c \ub9de\ucda4\ud615 \ubc31\uc2e0 \uac1c\ubc1c \uae30\uac04 \ub2e8\ucd95: AI \uae30\ubc18 \uc2e0\uc0dd\ud56d\uc6d0 \uc608\uce21 \uae30\uc220\uc740 \ub9de\ucda4\ud615 \ubc31\uc2e0 \uac1c\ubc1c \uae30\uac04\uc744 \ub2e8\ucd95\uc2dc\ud0a4\uba70 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud604\uc7a5 \ubc14\uc774\uc624\ub9ac\uc561\ud130 \uae30\ubc18 \ubcd1\uc6d0\uc758 &#8220;\uc790\uccb4&#8221; TIL \uc81c\uc870 \ucc44\ud0dd: \ud604\uc7a5 \ubc14\uc774\uc624\ub9ac\uc561\ud130 \ub3c4\uc785\uc73c\ub85c \ubcd1\uc6d0 \ub0b4 TIL(\uc885\uc591\uce68\uc724\ub9bc\ud504\uad6c) \uc81c\uc870\uac00 \uac00\ub2a5\ud574\uc9c0\uba74\uc11c \uce58\ub8cc \uc811\uadfc\uc131\uc774 \ud5a5\uc0c1\ub418\uace0 \uc2dc\uc7a5\uc774 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3.2. \uc81c\uc57d \uc694\uc778 (Restraints)<\/p>\n<p>*   30\ub9cc \ub2ec\ub7ec \uc774\uc0c1\uc758 \ub192\uc740 \uce58\ub8cc\uc81c \uac00\uaca9 \ubc0f \ubcf4\ud5d8 \uc0c1\ud55c\uc120: CAR-T \uce58\ub8cc\uc81c\ub294 \ucf54\uc2a4\ub2f9 30\ub9cc \ub2ec\ub7ec \uc774\uc0c1\uc73c\ub85c \ubcf4\ud5d8 \uc7ac\uc815\uc5d0 \ubd80\ub2f4\uc744 \uc8fc\uba70, \ubbf8\uad6d \ub4f1 \uc2dc\uc7a5\uc5d0\uc11c \uc131\uacfc \uae30\ubc18 \uacc4\uc57d\uc774 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Iovance\uc758 Amtagvi\ub294 51\ub9cc 5\ucc9c \ub2ec\ub7ec\ub85c \ucc45\uc815\ub418\uc5b4 \ud658\uc790 \ubc18\uc751\uc5d0 \ub530\ub978 \uc9c0\ubd88 \uc5f0\uacc4 \ud611\uc0c1\uc744 \uc720\ubc1c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc9d1\uc911 \uad00\ub9ac\uac00 \ud544\uc694\ud55c \uba74\uc5ed \uad00\ub828 \ubd80\uc791\uc6a9(irAEs): \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c\ub294 \ud3d0\ub834, \uc2ec\uadfc\uc5fc, \ub0b4\ubd84\ube44\ubcd1\uc99d \ub4f1 \uc804\ubb38\uc801\uc778 \uac10\ub3c5\uc774 \ud544\uc694\ud55c \ubd80\uc791\uc6a9\uc744 \uc720\ubc1c\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. 2025\ub144 NCCN \uba74\uc5ed\uce58\ub8cc \ub3c5\uc131 \uac00\uc774\ub4dc\ub77c\uc778\uc740 \ub2e4\ud559\uc81c \ud300 \ubc0f \uc2e0\uc18d\ud55c \uac1c\uc785 \uacbd\ub85c\uc758 \ud544\uc694\uc131\uc744 \uac15\uc870\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc2e0\ud765 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec PD-1\uc758 \uae00\ub85c\ubc8c \uac00\uaca9 \uc555\ub825: \uc720\ub7fd \ubc0f \uc2e0\ud765 \uc2dc\uc7a5\uc5d0\uc11c \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec PD-1\uc758 \ub4f1\uc7a5\uc740 \uae00\ub85c\ubc8c \uac00\uaca9 \uacbd\uc7c1\uc744 \uc2ec\ud654\uc2dc\ud0a4\uba70 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uc81c\uc57d \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc790\uac00 \uc138\ud3ec \uce58\ub8cc\uc81c\ub97c \uc704\ud55c \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uacf5\uae09 \ubcd1\ubaa9 \ud604\uc0c1: \uae00\ub85c\ubc8c \uc81c\uc870 \ud5c8\ube0c\uc5d0\uc11c \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uacf5\uae09\uc758 \ubcd1\ubaa9 \ud604\uc0c1\uc740 \uc790\uac00 \uc138\ud3ec \uce58\ub8cc\uc81c\uc758 \uc0dd\uc0b0 \ubc0f \uc0c1\uc5c5\uc801 \ucd9c\uc2dc\ub97c \uc9c0\uc5f0\uc2dc\ud0a4\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 4. \uc138\uadf8\uba3c\ud2b8\ubcc4 \ubd84\uc11d<\/p>\n<p>4.1. \uce58\ub8cc \uc720\ud615\ubcc4:<br \/>\n2025\ub144 \ub9e4\ucd9c\uc758 66.88%\ub97c \ucc28\uc9c0\ud55c \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc73c\uba70, 2031\ub144\uae4c\uc9c0 1,923.6\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubc18\uba74, \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4 \uce58\ub8cc\uc81c\ub294 23.28%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uba70, \ud6c4\uae30 \ub2e8\uacc4 \uc790\uc0b0 \uc99d\uac00 \ubc0f \uc81c\uc870 \ud30c\ud2b8\ub108\uc2ed\uc774 \uc131\uc7a5\uc744 \ub4b7\ubc1b\uce68\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4.2. \uc554 \uc720\ud615\ubcc4:<br \/>\n\ud3d0\uc554\uc740 2025\ub144 \ub9e4\ucd9c\uc758 25.12%\ub97c \ucc28\uc9c0\ud558\uba70 \ub2e8\uc77c \uc801\uc751\uc99d \uc911 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud608\uc561\uc554\uc740 21.42%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\ub85c \uc131\uc7a5\ud558\uc5ec 2031\ub144\uae4c\uc9c0 817.3\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0 \ub3c4\ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, CAR-T \uc2b9\uc778 \ubc0f \uc774\uc911\ud2b9\uc774\ud56d\uccb4 \uac1c\ubc1c\uc774 \ud658\uc790\uad70\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4.3. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4:<br \/>\n\ubcd1\uc6d0 \ubc0f \ud074\ub9ac\ub2c9\uc740 2025\ub144 \ub9e4\ucd9c\uc758 45.10%\ub97c \ucc28\uc9c0\ud558\uba70 \uae30\uc874\uc758 \uc778\ud504\ub77c\uc640 \ubcf4\ud5d8 \uc0c1\ud658 \uacbd\ub85c\uc758 \uc774\uc810\uc744 \ub204\ub9ac\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ud559\uc220 \ubc0f \uc554 \uc5f0\uad6c \uc13c\ud130\ub294 \uc5f0\uac04 17.96%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uba70 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uafb8\uc900\ud788 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud604\uc7a5 \ubc14\uc774\uc624\ub9ac\uc561\ud130\uc758 \uc18c\ud615\ud654\ub85c \uc9c0\uc5ed \ubcd1\uc6d0\uc5d0\uc11c\ub3c4 \uc790\uac00 \uc81c\ud488 \uc81c\uacf5\uc774 \uc2dc\uc791\ub418\uba70 \uc811\uadfc\uc131\uc774 \ubbfc\uc8fc\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4.4. \ud22c\uc5ec \uacbd\ub85c\ubcc4:<br \/>\n\uc815\ub9e5 \uc8fc\uc0ac\ub294 2025\ub144 \ub9e4\ucd9c\uc758 63.05%\ub97c \ucc28\uc9c0\ud558\uba70 \uc9c0\ubc30\uc801\uc785\ub2c8\ub2e4. \ud558\uc9c0\ub9cc \ud658\uc790 \uc911\uc2ec\uc758 \ud22c\uc5ec \ubc29\uc2dd\uc774 \uc778\uae30\ub97c \uc5bb\uc73c\uba70 \ud53c\ud558 \uc8fc\uc0ac \ubc0f \uc885\uc591 \ub0b4 \uc8fc\uc0ac\ub294 14.88%\uc758 CAGR\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud53c\ud558\uc8fc\uc0ac\ud615 \ub2c8\ubcfc\ub8e8\ub9d9\uc758 FDA \uc2b9\uc778\uc740 \uce58\ub8cc \uc2dc\uac04 \ub2e8\ucd95 \ubc0f \ud658\uc790 \ud3b8\uc758\uc131\uc744 \ud5a5\uc0c1\uc2dc\ucf30\uc73c\uba70, \uc885\uc591 \ub0b4 \uc8fc\uc0ac\ub294 &#8220;\ucc28\uac00\uc6b4&#8221; \uc885\uc591\uc744 &#8220;\ub728\uac70\uc6b4&#8221; \ubcd1\ubcc0\uc73c\ub85c \uc804\ud658\ud560 \uc7a0\uc7ac\ub825\uc73c\ub85c \uc8fc\ubaa9\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 5. \uc9c0\uc5ed\ubcc4 \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uae00\ub85c\ubc8c \ub9e4\ucd9c\uc758 48.10%\ub97c \ucc28\uc9c0\ud558\uba70 \uc120\ub450\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ube60\ub978 FDA \uc2b9\uc778, \uac15\ub825\ud55c \ubca4\ucc98 \uce90\ud53c\ud0c8 \uc720\uc785, \uc131\uacfc \uae30\ubc18 \ubcf4\ud5d8 \uc0c1\ud658 \uc2e4\ud5d8\uc774 \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9\uc744 \uc720\uc9c0\ud558\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 17.74%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc774 \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc911\uad6d\uc740 400\uac1c \uc774\uc0c1\uc758 CAR-T \uc784\uc0c1 \ud504\ub85c\uadf8\ub7a8\uacfc \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0 \uc5ed\ub7c9 \uad6c\ucd95\uc73c\ub85c \uc9c0\uc5ed \ubaa8\uba58\ud140\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc73c\uba70, \uc77c\ubcf8\uacfc \uc778\ub3c4\ub294 \uac01\uac01 \uc870\uae30 \ucc44\ud0dd \ubc0f \uc790\uad6d \uc81c\uc870 \uc5ed\ub7c9 \uac15\ud654\ub97c \ud1b5\ud574 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: EMA \uc218\uc900\uc758 \uc870\uc815\uc744 \uae30\ubc18\uc73c\ub85c \uafb8\uc900\ud55c \ud655\uc7a5\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc94EU \uc784\uc0c1 \uc2dc\ud5d8 \ub124\ud2b8\uc6cc\ud06c\ub294 \ud6a8\uc728\uc801\uc778 \ud658\uc790 \ubaa8\uc9d1\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uba70, \ubcf4\uac74 \uae30\uc220 \ud3c9\uac00 \uae30\uad00\uc740 \ube44\uc6a9 \ud6a8\uc728\uc131 \uae30\uc900\uc744 \uc801\uc6a9\ud558\uc5ec \uc131\uacfc \uae30\ubc18 \ud560\uc778 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \uc7a5\ub824\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc554 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\ub85c \ud30c\ud3b8\ud654\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. Merck, Bristol Myers Squibb, Roche\ub294 \ube14\ub85d\ubc84\uc2a4\ud130 \ud504\ub79c\ucc28\uc774\uc988\ub97c \ubcf4\uc720\ud558\uace0 \uc788\uc73c\ub098, mRNA \uc120\uad6c\uc790\uc778 BioNTech, Moderna, \uc138\ud3ec \uce58\ub8cc \uc804\ubb38 \uae30\uc5c5\uc778 Iovance, Kite \ub4f1\uacfc\uc758 \uacbd\uc7c1\uc774 \uc2ec\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. Pfizer\uc758 Seagen \uc778\uc218, Merck\uc758 Harpoon Therapeutics \uc778\uc218\uc640 \uac19\uc740 \uc804\ub7b5\uc801 \uc778\uc218\ub294 \uae30\uc5c5\ub4e4\uc774 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubaa8\ub2ec\ub9ac\ud2f0 \uc735\ud569\uc774 \uc804\ub7b5\uc801 \ucd08\uc810\uc774 \ub418\uace0 \uc788\uc73c\uba70, BioNTech\uc640 Bristol Myers Squibb\uc758 \uc774\uc911\ud2b9\uc774\ud56d\uccb4 \uac1c\ubc1c \ud611\ub825, Moderna\uc758 AI \ucd5c\uc801\ud654\ub41c \uc2e0\uc0dd\ud56d\uc6d0 \ubc1c\uacac \uc54c\uace0\ub9ac\uc998 \ud65c\uc6a9 \ub4f1\uc774 \ub300\ud45c\uc801\uc785\ub2c8\ub2e4. \ube44\uc6a9 \uc808\uac10 \ub610\ud55c \uc911\uc694\ud55c \uacbd\uc7c1 \uc694\uc18c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc73c\uba70, Novartis\uc758 CAR-T \uc81c\uc870 \ube44\uc6a9 \uc808\uac10, JW Therapeutics\uc758 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0\ub7c9 \uc99d\ub300 \ub178\ub825\uc774 \uc774\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 7. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 5\uc6d4: BioNTech\ub294 ASCO 2025\uc5d0\uc11c BNT327 \uc774\uc911\ud2b9\uc774\ud56d\uccb4 \uc9c4\ud589 \uc0c1\ud669 \ubc0f 2026\ub144\uae4c\uc9c0 20\uac1c 2\/3\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8 \uacc4\ud68d\uc744 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 5\uc6d4: ImmunityBio\ub294 \uc0ac\uc6b0\ub514\uc544\ub77c\ube44\uc544 \ubcf4\uac74 \uae30\uad00\uacfc IL-15 \uc288\ud37c\uc544\uace0\ub2c8\uc2a4\ud2b8 Cancer BioShield\ub97c \uc911\ub3d9 \uc804\uc5ed\uc5d0 \ubc30\uce58\ud558\ub294 \uacc4\uc57d\uc744 \uccb4\uacb0\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c \uc694\uc57d: \uc554 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5 \ubd84\uc11d<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc554 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud558\uba70, 2024\ub144 \uae30\uc900 \uc2dc\uc7a5 \uc815\uc758, \uc131\uc7a5 \ub3d9\uc778 \ubc0f \uc800\ud574 \uc694\uc778, \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc608\uce21, \uacbd\uc7c1 \ud658\uacbd, \uadf8\ub9ac\uace0 \ubbf8\ub798 \uc804\ub9dd\uc744 \ub2e4\ub8f9\ub2c8\ub2e4. \uc554 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc740 \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4, \uba74\uc5ed\uad00\ubb38 \uc5b5\uc81c\uc81c, \uc138\ud3ec \uae30\ubc18 \uce58\ub8cc\uc81c, \uce58\ub8cc\uc6a9 \ubc31\uc2e0, \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4 \uce58\ub8cc\uc81c \ub4f1 \ud658\uc790\uc758 \uba74\uc5ed \uccb4\uacc4\ub97c \ud65c\uc131\ud654 \ub610\ub294 \uc870\uc808\ud558\uc5ec \uc545\uc131 \uc885\uc591\uc744 \uce58\ub8cc\ud558\ub294 \ubaa8\ub4e0 \ucc98\ubc29 \uce58\ub8cc\uc81c\ub97c \ud3ec\ud568\ud569\ub2c8\ub2e4. \uc218\uc775\uc740 2024\ub144 \ubd88\ubcc0 \ubbf8\uad6d \ub2ec\ub7ec \uae30\uc900\uc73c\ub85c \uc81c\uc870\uc0ac \ucd9c\ud558 \uac00\uaca9(ex-manufacturer levels)\uc73c\ub85c \uc0b0\uc815\ub418\uba70, \uc804 \uc138\uacc4 \uc0c1\uc5c5 \ud310\ub9e4 \ubc0f \uc9c0\uc815 \ud658\uc790\/\ub3d9\uc815\uc801 \uc0ac\uc6a9 \ud504\ub85c\uadf8\ub7a8\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \ubcf4\uc870 \uce58\ub8cc\uc81c, \ud654\ud559 \uc694\ubc95, \uc804\uc784\uc0c1 R&#038;D \uc9c0\ucd9c\uc740 \ubc94\uc704\uc5d0\uc11c \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\uc778 \ubc0f \uc800\ud574 \uc694\uc778:<br \/>\n\uc2dc\uc7a5\uc758 \uc8fc\uc694 \uc131\uc7a5 \ub3d9\uc778\uc73c\ub85c\ub294 \uc804 \uc138\uacc4 \uace0\ud615 \uc885\uc591 \ubc1c\ubcd1\ub960 \uc99d\uac00, \ud654\ud559 \uc694\ubc95 \ubc0f \ud45c\uc801 \uc18c\ubd84\uc790 \uc81c\uc81c \ub300\ube44 \uc6b0\uc218\ud55c \uc7a5\uae30 \uc0dd\uc874\uc728, PD-1\/PD-L1 \uc5b5\uc81c\uc81c\uc5d0 \ub300\ud55c FDA\/EMA \uc2b9\uc778 \ud655\ub300, CAR-T \ubc0f \uc774\uc911\ud2b9\uc774\uc131 \ud56d\uccb4\uc758 \ud6c4\uae30 \uc784\uc0c1 \ub2e8\uacc4 \ud30c\uc774\ud504\ub77c\uc778 \uc99d\uac00, AI \ucd5c\uc801\ud654 \uc2e0\uc0dd\ud56d\uc6d0 \uc608\uce21\uc744 \ud1b5\ud55c \ub9de\ucda4\ud615 \ubc31\uc2e0 \uac1c\ubc1c \uae30\uac04 \ub2e8\ucd95, \uadf8\ub9ac\uace0 \ud604\uc7a5 \ubc14\uc774\uc624\ub9ac\uc561\ud130(point-of-care bioreactors)\ub97c \ud1b5\ud55c \ubcd1\uc6d0 \ub0b4 TIL(\uc885\uc591\uce68\uc724\ub9bc\ud504\uad6c) \uc81c\uc870 \ucc44\ud0dd \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 30\ub9cc \ub2ec\ub7ec\ub97c \ucd08\uacfc\ud558\ub294 \ub192\uc740 \uce58\ub8cc\uc81c \uac00\uaca9\uacfc \ubcf4\ud5d8 \uc0c1\ud658 \ud55c\ub3c4, \uc9d1\uc911\uc801\uc778 \uad00\ub9ac\uac00 \ud544\uc694\ud55c \uba74\uc5ed \uad00\ub828 \ubd80\uc791\uc6a9, \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec PD-1 \uc81c\ud488\uc758 \ub4f1\uc7a5\uc73c\ub85c \uc778\ud55c \uae00\ub85c\ubc8c \uac00\uaca9 \uc555\ubc15, \uadf8\ub9ac\uace0 \uc790\uac00 \uc138\ud3ec \uce58\ub8cc\uc81c\ub97c \uc704\ud55c \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uacf5\uae09 \ubcd1\ubaa9 \ud604\uc0c1 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\uc744 \ud1b5\ud574 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \uad6c\ub9e4\uc790 \ubc0f \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825, \ub300\uccb4\uc7ac\uc758 \uc704\ud611, \uadf8\ub9ac\uace0 \uacbd\uc7c1 \uac15\ub3c4 \ub610\ud55c \ud3c9\uac00\ub418\uc5c8\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21:<br \/>\n\uc554 \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc740 2026\ub144\uc5d0 1,645\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub3c4\ub2ec\ud588\uc73c\uba70, 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 13.62%\uc758 \uc131\uc7a5\ub960(CAGR)\uc744 \uae30\ub85d\ud558\uc5ec 3,114\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \ud655\ub300\ub420 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n\uce58\ub8cc \uc720\ud615\ubcc4\ub85c\ub294 \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4\uac00 2025\ub144 \ub9e4\ucd9c\uc758 66.88%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4 \uce58\ub8cc\uc81c\ub294 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 23.28%\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc554 \uc720\ud615\ubcc4\ub85c\ub294 \ud3d0\uc554, \uc720\ubc29\uc554, \ud751\uc0c9\uc885 \ubc0f \ud53c\ubd80\uc554, \uc804\ub9bd\uc120\uc554, \ud608\uc561\uc554(\ubc31\ud608\ubcd1, \ub9bc\ud504\uc885, \uace8\uc218\uc885) \ub4f1\uc774 \ubd84\uc11d\ub418\uc5c8\uc73c\uba70, \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\ub85c\ub294 \ubcd1\uc6d0 \ubc0f \ud074\ub9ac\ub2c9, \ud559\uc220 \ubc0f \uc554 \uc5f0\uad6c \uc13c\ud130, \uc678\ub798 \ubc0f \uc804\ubb38 \uc8fc\uc785 \uc13c\ud130\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4. \ud22c\uc5ec \uacbd\ub85c\ubcc4\ub85c\ub294 \uc815\ub9e5 \uc8fc\uc0ac \ubc0f \ud53c\ud558\/\uc885\uc591 \ub0b4 \ud22c\uc5ec\uac00 \ud3ec\ud568\ub429\ub2c8\ub2e4.<br \/>\n\uc9c0\uc5ed\ubcc4\ub85c\ub294 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\uac00 \ubd84\uc11d\ub418\uc5c8\uc73c\uba70, \ud2b9\ud788 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 17.74%\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubc0f \uc8fc\uc694 \uae30\uc5c5:<br \/>\n\ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4 \ubc0f \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d\uc744 \ud3ec\ud568\ud55c \uacbd\uc7c1 \ud658\uacbd\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8f9\ub2c8\ub2e4. Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Co., Merck &#038; Co., Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Novartis AG, GSK plc, Eli Lilly and Company, AbbVie Inc., Johnson &#038; Johnson (Janssen), Regeneron Pharmaceuticals, Sanofi, BeiGene Ltd, Seagen Inc., BioNTech SE, Moderna, Inc., Iovance Biotherapeutics, OSE Immunotherapeutics SA, Innovent Biologics \ub4f1 \uc8fc\uc694 \uae00\ub85c\ubc8c \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uc774 \uc81c\uacf5\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc5f0\uad6c \ubc29\ubc95\ub860:<br \/>\n\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc0c1\ud5a5\uc2dd(bottom-up) \ubc0f \ud558\ud5a5\uc2dd(top-down) \ud558\uc774\ube0c\ub9ac\ub4dc \ubaa8\ub378\uc744 \uc801\uc6a9\ud55c \uacac\uace0\ud55c \uc5f0\uad6c \ubc29\ubc95\ub860\uc744 \uae30\ubc18\uc73c\ub85c \ud569\ub2c8\ub2e4. 1\ucc28 \uc5f0\uad6c\ub294 \uc758\ub8cc \uc885\uc591 \uc804\ubb38\uc758, \ubcd1\uc6d0 \uc57d\uc0ac, \ubcf4\ud5d8\uc0ac, \uba74\uc5ed\uce58\ub8cc \uc5f0\uad6c\uc790\ub4e4\uacfc\uc758 \uc778\ud130\ubdf0\ub97c \ud1b5\ud574 \uc2e4\uc81c \ucc44\ud0dd\ub960, \ud22c\uc5ec \ud328\ud134, \ud3c9\uade0 \ud310\ub9e4 \uac00\uaca9, \ubcf4\ud5d8 \uc0c1\ud658 \ubb38\uc81c \ub4f1\uc744 \ud30c\uc545\ud588\uc2b5\ub2c8\ub2e4. 2\ucc28 \uc5f0\uad6c\ub294 WHO GLOBOCAN, CDC SEER, Eurostat \uc554 \ub4f1\ub85d \ub370\uc774\ud130, FDA Drugs@FDA, EMA \ubcf4\uace0\uc11c, ClinicalTrials.gov, \uae30\uc5c5 \uc7ac\ubb34 \ubcf4\uace0\uc11c, Medicare &#038; Medicaid Services \uac00\uaca9 \ud30c\uc77c \ub4f1 \uad11\ubc94\uc704\ud55c \uacf5\uac1c \uc790\ub8cc\ub97c \ud65c\uc6a9\ud588\uc2b5\ub2c8\ub2e4. \ubaa8\ub378 \uacb0\uacfc\ub294 \ub3c5\ub9bd\uc801\uc778 \ud310\ub9e4 \uac10\uc0ac \ubc0f \uad6d\uac00 \uc218\uc785 \ub370\uc774\ud130\uc640 \ube44\uad50\ud558\uc5ec \uac80\uc99d\ub418\uba70, \uc8fc\uc694 \uc2b9\uc778, \uc548\uc804\uc131 \uc2e0\ud638 \ub610\ub294 \uac00\uaca9 \uc7ac\uc124\uc815 \ubc1c\uc0dd \uc2dc \ub9e4\ub144 \ub610\ub294 \ub354 \ube60\ub974\uac8c \uc5c5\ub370\uc774\ud2b8\ub429\ub2c8\ub2e4. Mordor Intelligence\uc758 \ubcf4\uace0\uc11c\ub294 \ud22c\uba85\ud55c \ubc94\uc704 \uc120\uc815, \uc2e4\uc2dc\uac04 \uac00\uaca9 \ucd94\uc801, \uc2e0\uc18d\ud55c \uc5c5\ub370\uc774\ud2b8 \uc8fc\uae30\ub97c \ud1b5\ud574 \uc2e0\ub8b0\ud560 \uc218 \uc788\ub294 \uae30\uc900\uc120\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-32562","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/32562"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=32562"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/32562\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=32562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=32562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=32562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}